E2F1 and glioblastoma: In EE-015A (chr6:44635140A>G), the mutation increased the predicted binding affinity for heat-shock transcription factor 1 (HSF1) and introduced a novel binding site for E2F1, both linked to GBM progression (Fig. 1E; Fig. S3A).